Immune Netw.  2023 Jun;23(3):e29. 10.4110/in.2023.23.e29.

The Immunosuppressive Potential of Cholesterol Sulfate Through T Cell Microvilli Disruption

• Park JS
• Chung IJ
• Kim HR
• Jun CD

• KMID: 2544692
• DOI: http://doi.org/10.4110/in.2023.23.e29

Abstract

Cholesterol (CL) is required for various biomolecular production processes, including those of cell membrane components. Therefore, to meet these needs, CL is converted into various derivatives. Among these derivatives is cholesterol sulfate (CS), a naturally produced CL derivative by the sulfotransferase family 2B1 (SULT2B1), which is widely present in human plasma. CS is involved in cell membrane stabilization, blood clotting, keratinocyte differentiation, and TCR nanocluster deformation. This study shows that treatment of T cells with CS resulted in the decreased surface expression of some surface T-cell proteins and reduced IL-2 release. Furthermore, T cells treated with CS significantly reduced lipid raft contents and membrane CLs. Surprisingly, using the electron microscope, we also observed that CS led to the disruption of T-cell microvilli, releasing small microvilli particles containing TCRs and other microvillar proteins. However, in vivo, T cells with CS showed aberrant migration to high endothelial venules and limited infiltrating splenic T-cell zones compared with the untreated T cells. Additionally, we observed significant alleviation of atopic dermatitis in mice injected with CS in the animal model. Based on these results, we conclude that CS is an immunosuppressive natural lipid that impairs TCR signaling by disrupting microvillar function in T cells, suggesting its usefulness as a therapeutic agent for alleviating T-cellmediated hypersensitivity and a potential target for treating autoimmune diseases.

Keyword

T cells; Cholesterol; Cholesterol sulfate; Cell microvilli disruption; Autoimmune disease